首页|雷珠单抗辅助激光手术对Ⅱ型糖尿病性视网膜病变患者的影响

雷珠单抗辅助激光手术对Ⅱ型糖尿病性视网膜病变患者的影响

扫码查看
目的 探讨雷珠单抗辅助激光手术对Ⅱ型糖尿病性视网膜病变(DR)患者视网膜厚度、视力恢复的影响。方法 回顾性选取2021年2月至2023年2月新郑华信民生医院的Ⅱ型DR患者140例,按照不同手术方法分为对照组(70例)和观察组(70例),对照组行激光治疗术,观察组行雷珠单抗辅助激光手术。比较2组视力水平、临床症状改善时间、血流动力学[舒张末期血流速度(EDV)、峰值血流速度(PSV)、血流阻力指数(RI)]水平、低视力者生活质量量表(CLVQOL)评分及并发症发生率。结果 观察组渗出吸收时间、眼底出血吸收时间、视网膜水肿吸收时间短于对照组,差异有统计学意义(P<0。05)。观察组术后1个月视力值、最佳矫正视力较高,视野灰度值、视网膜厚度小于对照组,差异有统计学意义(P<0。05)。观察组术后1个月EDV、PSV高于对照组,RI低于对照组,差异有统计学意义(P<0。05)。观察组术后1个月CLVQOL评分高于对照组,差异有统计学意义(P<0。05)。观察组并发症发生率低于对照组,差异有统计学意义(P<0。05)。结论 雷珠单抗辅助激光手术能促进Ⅱ型DR患者眼部血液循环,降低视网膜厚度,改善视力,同时可降低术后并发症发生率,提高术后生活质量。
Study on laser surgery assisted with Leizumab for type Ⅱ diabetes retinopathy
Objective To investigate the effect of laser surgery assisted with Leizumab on retinal thick-ness and visual acuity recovery in patients with type Ⅱ diabetes retinopathy(DR).Methods A total of 140 type Ⅱ DR patients in Hopeshine-Minsheng Hospital of Xinzheng from February 2021 to February 2023 were selected retrospectively,and divided into the control group(70 cases)and the observation group(70 cases)ac-cording to different surgical methods.The control group received laser treatment,while the observation group received laser surgery assisted by Leizumab.The visual acuity levels,time to clinical symptom improvement,hemodynamic levels[end diastolic blood flow velocity(EDV),peak blood flow velocity(PSV),blood flow re-sistance index(RI)],low-vision quality of life(CLVQOL)scores,and incidence of complications between two groups were compared.Results The observation group had shorter absorption times for exudate,fundus hem-orrhage,and retinal edema compared to the control group,with statistical significance(P<0.05).The obser-vation group had higher visual acuity and the best corrected visual acuity at one month after surgery,and the grayscale value and retinal thickness of the field of view were smaller than those of the control group,with statistical significance(P<0.05).The EDV and PSV levels in the observation group were higher than those in the control group one month after surgery,while the RI levels were lower than those in the control group,with statistical significance(P<0.05).The CLVQOL score of the observation group was higher than that of the control group one month after surgery,and the difference was statistically significant(P<0.05).The inci-dence of complications in the observation group was lower than that in the control group,and the difference was statistically significant(P<0.05).Conclusion Laser surgery assisted with Leizumab can promote blood circulation in the eyes of type Ⅱ DR patients,reduce retinal thickness,improve vision,reduce the incidence of postoperative complications,and improve postoperative quality of life.

LeizumabDiabetesLaser surgeryRetinopathy

吴瑞婵、潘俊辉、陈志毅

展开 >

新郑华信民生医院眼科,河南新郑 451100

郑州市第二人民医院眼科,河南郑州 450000

雷珠单抗 糖尿病 激光手术 视网膜病变

2024

现代医药卫生
重庆市卫生信息中心

现代医药卫生

影响因子:0.758
ISSN:1009-5519
年,卷(期):2024.40(15)